vs
IMMUCELL CORP（ICCC）与永明金融（TOP）财务数据对比。点击上方公司名可切换其他公司
IMMUCELL CORP的季度营收约是永明金融的1.9倍（$5.5M vs $2.9M），永明金融净利率更高（6.6% vs -2.5%，领先9.2%）
ImmuCell Corp是一家总部位于美国的动物健康生物技术企业，主要研发、生产和销售以奶牛为主的家畜相关保健与治疗产品，核心产品包括乳腺炎等常见牛类疾病的防治方案，主要服务北美地区的畜牧养殖户和兽医机构。
永明金融是一家总部位于加拿大安大略省多伦多的金融服务公司，创立于1865年，业务遍及全球，主营人寿保险、财富管理与资产管理。截至2024年，该公司管理资产规模超过1.3万亿加元，服务覆盖加拿大、美国、亚洲及多个其他市场。
ICCC vs TOP — 直观对比
营收规模更大
ICCC
是对方的1.9倍
$2.9M
净利率更高
TOP
高出9.2%
-2.5%
损益表 — Q3 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $5.5M | $2.9M |
| 净利润 | $-139.7K | $190.5K |
| 毛利率 | 42.9% | — |
| 营业利润率 | 0.4% | — |
| 净利率 | -2.5% | 6.6% |
| 营收同比 | -8.4% | — |
| 净利润同比 | 80.1% | — |
| 每股收益（稀释后） | $-0.02 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ICCCTOP
| Q3 25 | $5.5M | $2.9M | ||
| Q2 25 | $6.4M | — | ||
| Q1 25 | $8.1M | — | ||
| Q4 24 | $7.8M | — | ||
| Q3 24 | $6.0M | — | ||
| Q2 24 | $5.5M | — | ||
| Q1 24 | $7.3M | — | ||
| Q4 23 | $5.1M | — |
净利润ICCCTOP
| Q3 25 | $-139.7K | $190.5K | ||
| Q2 25 | $501.9K | — | ||
| Q1 25 | $1.4M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-701.7K | — | ||
| Q2 24 | $-1.5M | — | ||
| Q1 24 | $-437.9K | — | ||
| Q4 23 | — | — |
毛利率ICCCTOP
| Q3 25 | 42.9% | — | ||
| Q2 25 | 43.7% | — | ||
| Q1 25 | 41.6% | — | ||
| Q4 24 | 36.5% | — | ||
| Q3 24 | 26.3% | — | ||
| Q2 24 | 22.5% | — | ||
| Q1 24 | 31.6% | — | ||
| Q4 23 | 24.7% | — |
营业利润率ICCCTOP
| Q3 25 | 0.4% | — | ||
| Q2 25 | 8.8% | — | ||
| Q1 25 | 13.9% | — | ||
| Q4 24 | 8.0% | — | ||
| Q3 24 | -9.6% | — | ||
| Q2 24 | -25.3% | — | ||
| Q1 24 | -4.1% | — | ||
| Q4 23 | -19.7% | — |
净利率ICCCTOP
| Q3 25 | -2.5% | 6.6% | ||
| Q2 25 | 7.8% | — | ||
| Q1 25 | 17.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -11.7% | — | ||
| Q2 24 | -28.0% | — | ||
| Q1 24 | -6.0% | — | ||
| Q4 23 | — | — |
每股收益（稀释后）ICCCTOP
| Q3 25 | $-0.02 | — | ||
| Q2 25 | $0.06 | — | ||
| Q1 25 | $0.16 | — | ||
| Q4 24 | $0.09 | — | ||
| Q3 24 | $-0.09 | — | ||
| Q2 24 | $-0.20 | — | ||
| Q1 24 | $-0.06 | — | ||
| Q4 23 | $-0.15 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.9M | $14.8M |
| 总债务越低越好 | $9.5M | — |
| 股东权益账面价值 | $29.8M | $35.0M |
| 总资产 | $45.7M | $64.1M |
| 负债/权益比越低杠杆越低 | 0.32× | — |
8季度趋势，按日历期对齐
现金及短期投资ICCCTOP
| Q3 25 | $3.9M | $14.8M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $3.8M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $1.3M | — | ||
| Q1 24 | $960.3K | — | ||
| Q4 23 | $978.7K | — |
总债务ICCCTOP
| Q3 25 | $9.5M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $8.7M | — | ||
| Q4 24 | $9.0M | — | ||
| Q3 24 | $9.4M | — | ||
| Q2 24 | $9.8M | — | ||
| Q1 24 | $10.2M | — | ||
| Q4 23 | $10.5M | — |
股东权益ICCCTOP
| Q3 25 | $29.8M | $35.0M | ||
| Q2 25 | $29.9M | — | ||
| Q1 25 | $29.0M | — | ||
| Q4 24 | $27.5M | — | ||
| Q3 24 | $26.4M | — | ||
| Q2 24 | $23.5M | — | ||
| Q1 24 | $24.6M | — | ||
| Q4 23 | $25.0M | — |
总资产ICCCTOP
| Q3 25 | $45.7M | $64.1M | ||
| Q2 25 | $46.7M | — | ||
| Q1 25 | $45.6M | — | ||
| Q4 24 | $45.1M | — | ||
| Q3 24 | $44.4M | — | ||
| Q2 24 | $41.9M | — | ||
| Q1 24 | $43.1M | — | ||
| Q4 23 | $43.8M | — |
负债/权益比ICCCTOP
| Q3 25 | 0.32× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.30× | — | ||
| Q4 24 | 0.33× | — | ||
| Q3 24 | 0.36× | — | ||
| Q2 24 | 0.42× | — | ||
| Q1 24 | 0.41× | — | ||
| Q4 23 | 0.42× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.2M | — |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | — |
| 自由现金流率自由现金流/营收 | -32.3% | — |
| 资本支出强度资本支出/营收 | 10.8% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $715.4K | — |
8季度趋势，按日历期对齐
经营现金流ICCCTOP
| Q3 25 | $-1.2M | — | ||
| Q2 25 | $1.6M | — | ||
| Q1 25 | $1.6M | — | ||
| Q4 24 | $-3.1K | — | ||
| Q3 24 | $-639.3K | — | ||
| Q2 24 | $581.8K | — | ||
| Q1 24 | $418.5K | — | ||
| Q4 23 | $-723.1K | — |
自由现金流ICCCTOP
| Q3 25 | $-1.8M | — | ||
| Q2 25 | $1.4M | — | ||
| Q1 25 | $1.2M | — | ||
| Q4 24 | $-199.3K | — | ||
| Q3 24 | $-727.7K | — | ||
| Q2 24 | $471.0K | — | ||
| Q1 24 | $348.1K | — | ||
| Q4 23 | $-804.4K | — |
自由现金流率ICCCTOP
| Q3 25 | -32.3% | — | ||
| Q2 25 | 22.4% | — | ||
| Q1 25 | 15.4% | — | ||
| Q4 24 | -2.6% | — | ||
| Q3 24 | -12.1% | — | ||
| Q2 24 | 8.6% | — | ||
| Q1 24 | 4.8% | — | ||
| Q4 23 | -15.8% | — |
资本支出强度ICCCTOP
| Q3 25 | 10.8% | — | ||
| Q2 25 | 2.4% | — | ||
| Q1 25 | 4.1% | — | ||
| Q4 24 | 2.5% | — | ||
| Q3 24 | 1.5% | — | ||
| Q2 24 | 2.0% | — | ||
| Q1 24 | 1.0% | — | ||
| Q4 23 | 1.6% | — |
现金转化率ICCCTOP
| Q3 25 | — | — | ||
| Q2 25 | 3.19× | — | ||
| Q1 25 | 1.09× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
